Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Combination of Paclitaxel-bevacizumab ± Atezolizumab in Patients With Advanced NSCLC Progressing After Immunotherapy & ChemotherapyNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmActive, not recruitingPhase 22025-11-18NCT05781308

1 results · Page 1 of 1

Swipe the table sideways for more columns.

44 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
APHM Hôpital NordMarseilleFrance3
Centre Georges-François LeclercDijonFrance15
Centre Hospitalier Intercommunal Créteil CHICCréteilFrance1
Centre Léon BérardLyonFrance77
CH Annecy GenevoisPringyFrance5
CH AvignonAvignonFrance4
CH CholetCholetFrance5
CH Côte BasqueBayonneFrance2
CH Le mansLe MansFrance14
CH PasteurColmarFrance1
CH PAUPauFrance4
CH VersaillesLe ChesnayFrance6
CH Villefranche Nord OuestVillefranche-sur-SaôneFrance1
CHD VendéeLa Roche-sur-YonFrance41
CHR OrléansOrléansFrance9
CHU AmiensAmiensFrance49
CHU Besançon - Hôpital J. MINJOZBesançonFrance2
CHU Bordeaux Haut-LévèquePessacFrance1
CHU Côte de NacreCaenFrance3
CHU d'AngersAngersFrance5
CHU DijonDijonFrance37
CHU Gabriel MontpiedClermont-FerrandFrance6
CHU GrenobleGrenobleFrance19
CHU LilleLilleFrance63
Chu LimogesLimogesFrance24